Prostatype Genomics AB
F:PGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Prostatype Genomics AB
F:PGO
|
SE |
|
Ion Video Ltd
OTC:LNNTD
|
AU |
|
J
|
Jinyoung Co Ltd
KOSDAQ:285800
|
KR |
|
GHST World Inc
OTC:GHST
|
US |
|
Rand Mining Ltd
F:014
|
AU |
|
D
|
Dawonsys Co Ltd
KOSDAQ:068240
|
KR |
|
Gulf Manganese Corporation Ltd
ASX:GMC
|
AU |
|
S
|
Summit Royalties Ltd
OTC:SUMMF
|
CA |
|
Quick Intelligent Equipment Co Ltd
SSE:603203
|
CN |
|
B
|
Bibica Corp
VN:BBC
|
VN |
|
Future Supply Chain Solutions Ltd
NSE:FSC
|
IN |
|
Cosco Shipping International (Singapore) Co Ltd
SGX:F83
|
SG |
|
Proton Motor Power Systems PLC
LSE:PPS
|
UK |
|
H
|
Havanna Holding SA
BCBA:HAVA
|
AR |
|
BurTech Acquisition Corp
OTC:BRKH
|
US |
|
P
|
PIERER Mobility AG
F:PMAG
|
AT |
Bankruptcy Probability
Prostatype Genomics AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Prostatype Genomics AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
P
|
Prostatype Genomics AB
STO:PROGEN
|
52.2m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
65.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Prostatype Genomics AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Prostatype Genomics AB has no debt.
You can find a full breakdown on its Balance Sheet.
